New Report on Drug Regulatory Approvals and the Opportunities for Antimicrobial Innovation

  12 July 2022

A new report by the One Health Trust, Drug Regulatory Approvals and Opportunities for Antimicrobial Innovation – Perspectives from Brazil, India and South Africa, describes the current climate for antimicrobial innovation, focusing on regulatory pathways supporting accelerated drug approvals in Brazil, India, and South Africa.

Produced with the support of the AMR Industry Alliance, the report highlights the importance of explicitly recognizing new antimicrobials targeting serious or life-threatening infections as a critical unmet medical need and formalizing their inclusion in regulatory frameworks for accelerated drug approval.

Download the report here

Further reading: AMR Industry Alliance
Author(s): AMR Industry Alliance
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed